Industry Research Reports
Home > Reports > Medical Devices & Consumables > STD Rapid Antibody Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
STD Rapid Antibody Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Industry: Medical Devices & Consumables
Published Date: 2025-01-13
Pages: 128 Pages
Report ld: 3499318
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
STD Rapid Antibody Test Market Size(US$)
CAGR 2025-2031
5.1%
Market Size,2031
USD 100
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 74.4 million
Market Forecast in 2031(Value)
US$ 100 million
CAGR
5.1%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for STD Rapid Antibody Test was estimated to be worth US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
With the increasing openness of society, sexual health has gained significant attention. The STD Rapid Antibody Test has become an essential product in the market due to its rapid and convenient nature. This testing method can quickly detect antibodies related to various sexually transmitted diseases in a short period, aiding individuals in understanding their sexual health status and taking necessary measures for early treatment and prevention. Market trends indicate that modern individuals are placing a higher emphasis on health, particularly sexual health. As a result, there is a growing demand for STD Rapid Antibody Tests in medical facilities, sexual health institutions, and even through online retail channels. However, consumers are also becoming more concerned about the accuracy and reliability of such products. Manufacturers must rigorously ensure product quality to guarantee result accuracy and win the trust of consumers.
This report aims to provide a comprehensive presentation of the global market for STD Rapid Antibody Test, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of STD Rapid Antibody Test by region & country, by Type, and by Application.
The STD Rapid Antibody Test market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding STD Rapid Antibody Test.
MARKET SEGMENTATION
By Company
- Blue Cross Bio-Medical (Beijing)
- Guangzhou Wondfo Biotech
- OraSure
- Roche Diagnostics
- Abbott
- Bio-Rad Laboratories
- BioMerieux
- Creative Diagnostics
- Beijing Wantai Biological Pharmacy
- Chembio Diagnostic Systems
- InTec
- Meril Life
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Chlamydia Testing
- Gonorrhoea Testing
- Hepatitis C Testing
- HIV Testing
- Syphilis Testing
- Others
Segment by Application
- Hospital
- Homecare
- Diagnostic Centres
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of STD Rapid Antibody Test manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of STD Rapid Antibody Test in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of STD Rapid Antibody Test in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 STD Rapid Antibody Test Product Introduction
1.2 Global STD Rapid Antibody Test Market Size Forecast
1.2.1 Global STD Rapid Antibody Test Sales Value (2020-2031)
1.2.2 Global STD Rapid Antibody Test Sales Volume (2020-2031)
1.2.3 Global STD Rapid Antibody Test Sales Price (2020-2031)
1.3 STD Rapid Antibody Test Market Trends & Drivers
1.3.1 STD Rapid Antibody Test Industry Trends
1.3.2 STD Rapid Antibody Test Market Drivers & Opportunity
1.3.3 STD Rapid Antibody Test Market Challenges
1.3.4 STD Rapid Antibody Test Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global STD Rapid Antibody Test Players Revenue Ranking (2024)
2.2 Global STD Rapid Antibody Test Revenue by Company (2020-2025)
2.3 Global STD Rapid Antibody Test Players Sales Volume Ranking (2024)
2.4 Global STD Rapid Antibody Test Sales Volume by Company Players (2020-2025)
2.5 Global STD Rapid Antibody Test Average Price by Company (2020-2025)
2.6 Key Manufacturers STD Rapid Antibody Test Manufacturing Base and Headquarters
2.7 Key Manufacturers STD Rapid Antibody Test Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of STD Rapid Antibody Test
2.9 STD Rapid Antibody Test Market Competitive Analysis
2.9.1 STD Rapid Antibody Test Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by STD Rapid Antibody Test Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Rapid Antibody Test as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Chlamydia Testing
3.1.2 Gonorrhoea Testing
3.1.3 Hepatitis C Testing
3.1.4 HIV Testing
3.1.5 Syphilis Testing
3.1.6 Others
3.2 Global STD Rapid Antibody Test Sales Value by Type
3.2.1 Global STD Rapid Antibody Test Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global STD Rapid Antibody Test Sales Value, by Type (2020-2031)
3.2.3 Global STD Rapid Antibody Test Sales Value, by Type (%) (2020-2031)
3.3 Global STD Rapid Antibody Test Sales Volume by Type
3.3.1 Global STD Rapid Antibody Test Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global STD Rapid Antibody Test Sales Volume, by Type (2020-2031)
3.3.3 Global STD Rapid Antibody Test Sales Volume, by Type (%) (2020-2031)
3.4 Global STD Rapid Antibody Test Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Homecare
4.1.3 Diagnostic Centres
4.2 Global STD Rapid Antibody Test Sales Value by Application
4.2.1 Global STD Rapid Antibody Test Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global STD Rapid Antibody Test Sales Value, by Application (2020-2031)
4.2.3 Global STD Rapid Antibody Test Sales Value, by Application (%) (2020-2031)
4.3 Global STD Rapid Antibody Test Sales Volume by Application
4.3.1 Global STD Rapid Antibody Test Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global STD Rapid Antibody Test Sales Volume, by Application (2020-2031)
4.3.3 Global STD Rapid Antibody Test Sales Volume, by Application (%) (2020-2031)
4.4 Global STD Rapid Antibody Test Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global STD Rapid Antibody Test Sales Value by Region
5.1.1 Global STD Rapid Antibody Test Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global STD Rapid Antibody Test Sales Value by Region (2020-2025)
5.1.3 Global STD Rapid Antibody Test Sales Value by Region (2026-2031)
5.1.4 Global STD Rapid Antibody Test Sales Value by Region (%), (2020-2031)
5.2 Global STD Rapid Antibody Test Sales Volume by Region
5.2.1 Global STD Rapid Antibody Test Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global STD Rapid Antibody Test Sales Volume by Region (2020-2025)
5.2.3 Global STD Rapid Antibody Test Sales Volume by Region (2026-2031)
5.2.4 Global STD Rapid Antibody Test Sales Volume by Region (%), (2020-2031)
5.3 Global STD Rapid Antibody Test Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America STD Rapid Antibody Test Sales Value, 2020-2031
5.4.2 North America STD Rapid Antibody Test Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe STD Rapid Antibody Test Sales Value, 2020-2031
5.5.2 Europe STD Rapid Antibody Test Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific STD Rapid Antibody Test Sales Value, 2020-2031
5.6.2 Asia Pacific STD Rapid Antibody Test Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America STD Rapid Antibody Test Sales Value, 2020-2031
5.7.2 South America STD Rapid Antibody Test Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa STD Rapid Antibody Test Sales Value, 2020-2031
5.8.2 Middle East & Africa STD Rapid Antibody Test Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions STD Rapid Antibody Test Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions STD Rapid Antibody Test Sales Value
6.2.1 Key Countries/Regions STD Rapid Antibody Test Sales Value, 2020-2031
6.2.2 Key Countries/Regions STD Rapid Antibody Test Sales Volume, 2020-2031
6.3 United States
6.3.1 United States STD Rapid Antibody Test Sales Value, 2020-2031
6.3.2 United States STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
6.3.3 United States STD Rapid Antibody Test Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe STD Rapid Antibody Test Sales Value, 2020-2031
6.4.2 Europe STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe STD Rapid Antibody Test Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China STD Rapid Antibody Test Sales Value, 2020-2031
6.5.2 China STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
6.5.3 China STD Rapid Antibody Test Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan STD Rapid Antibody Test Sales Value, 2020-2031
6.6.2 Japan STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan STD Rapid Antibody Test Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea STD Rapid Antibody Test Sales Value, 2020-2031
6.7.2 South Korea STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea STD Rapid Antibody Test Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia STD Rapid Antibody Test Sales Value, 2020-2031
6.8.2 Southeast Asia STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia STD Rapid Antibody Test Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India STD Rapid Antibody Test Sales Value, 2020-2031
6.9.2 India STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
6.9.3 India STD Rapid Antibody Test Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Blue Cross Bio-Medical (Beijing)
7.1.1 Blue Cross Bio-Medical (Beijing) Company Information
7.1.2 Blue Cross Bio-Medical (Beijing) Introduction and Business Overview
7.1.3 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Product Offerings
7.1.5 Blue Cross Bio-Medical (Beijing) Recent Development
7.2 Guangzhou Wondfo Biotech
7.2.1 Guangzhou Wondfo Biotech Company Information
7.2.2 Guangzhou Wondfo Biotech Introduction and Business Overview
7.2.3 Guangzhou Wondfo Biotech STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Guangzhou Wondfo Biotech STD Rapid Antibody Test Product Offerings
7.2.5 Guangzhou Wondfo Biotech Recent Development
7.3 OraSure
7.3.1 OraSure Company Information
7.3.2 OraSure Introduction and Business Overview
7.3.3 OraSure STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 OraSure STD Rapid Antibody Test Product Offerings
7.3.5 OraSure Recent Development
7.4 Roche Diagnostics
7.4.1 Roche Diagnostics Company Information
7.4.2 Roche Diagnostics Introduction and Business Overview
7.4.3 Roche Diagnostics STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Roche Diagnostics STD Rapid Antibody Test Product Offerings
7.4.5 Roche Diagnostics Recent Development
7.5 Abbott
7.5.1 Abbott Company Information
7.5.2 Abbott Introduction and Business Overview
7.5.3 Abbott STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Abbott STD Rapid Antibody Test Product Offerings
7.5.5 Abbott Recent Development
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Company Information
7.6.2 Bio-Rad Laboratories Introduction and Business Overview
7.6.3 Bio-Rad Laboratories STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Bio-Rad Laboratories STD Rapid Antibody Test Product Offerings
7.6.5 Bio-Rad Laboratories Recent Development
7.7 BioMerieux
7.7.1 BioMerieux Company Information
7.7.2 BioMerieux Introduction and Business Overview
7.7.3 BioMerieux STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 BioMerieux STD Rapid Antibody Test Product Offerings
7.7.5 BioMerieux Recent Development
7.8 Creative Diagnostics
7.8.1 Creative Diagnostics Company Information
7.8.2 Creative Diagnostics Introduction and Business Overview
7.8.3 Creative Diagnostics STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Creative Diagnostics STD Rapid Antibody Test Product Offerings
7.8.5 Creative Diagnostics Recent Development
7.9 Beijing Wantai Biological Pharmacy
7.9.1 Beijing Wantai Biological Pharmacy Company Information
7.9.2 Beijing Wantai Biological Pharmacy Introduction and Business Overview
7.9.3 Beijing Wantai Biological Pharmacy STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Beijing Wantai Biological Pharmacy STD Rapid Antibody Test Product Offerings
7.9.5 Beijing Wantai Biological Pharmacy Recent Development
7.10 Chembio Diagnostic Systems
7.10.1 Chembio Diagnostic Systems Company Information
7.10.2 Chembio Diagnostic Systems Introduction and Business Overview
7.10.3 Chembio Diagnostic Systems STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Chembio Diagnostic Systems STD Rapid Antibody Test Product Offerings
7.10.5 Chembio Diagnostic Systems Recent Development
7.11 InTec
7.11.1 InTec Company Information
7.11.2 InTec Introduction and Business Overview
7.11.3 InTec STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 InTec STD Rapid Antibody Test Product Offerings
7.11.5 InTec Recent Development
7.12 Meril Life
7.12.1 Meril Life Company Information
7.12.2 Meril Life Introduction and Business Overview
7.12.3 Meril Life STD Rapid Antibody Test Sales, Revenue, Price and Gross Margin (2020-2025)
7.12.4 Meril Life STD Rapid Antibody Test Product Offerings
7.12.5 Meril Life Recent Development
8 Industry Chain Analysis
8.1 STD Rapid Antibody Test Industrial Chain
8.2 STD Rapid Antibody Test Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 STD Rapid Antibody Test Sales Model
8.5.2 Sales Channel
8.5.3 STD Rapid Antibody Test Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. STD Rapid Antibody Test Market Trends
Table 2. STD Rapid Antibody Test Market Drivers & Opportunity
Table 3. STD Rapid Antibody Test Market Challenges
Table 4. STD Rapid Antibody Test Market Restraints
Table 5. Global STD Rapid Antibody Test Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global STD Rapid Antibody Test Revenue Market Share by Company (2020-2025)
Table 7. Global STD Rapid Antibody Test Sales Volume by Company (2020-2025) & (K Units)
Table 8. Global STD Rapid Antibody Test Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market STD Rapid Antibody Test Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers STD Rapid Antibody Test Manufacturing Base and Headquarters
Table 11. Key Manufacturers STD Rapid Antibody Test Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of STD Rapid Antibody Test
Table 13. Global STD Rapid Antibody Test Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in STD Rapid Antibody Test as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global STD Rapid Antibody Test Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global STD Rapid Antibody Test Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global STD Rapid Antibody Test Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global STD Rapid Antibody Test Sales Market Share in Value by Type (2020-2025)
Table 20. Global STD Rapid Antibody Test Sales Market Share in Value by Type (2026-2031)
Table 21. Global STD Rapid Antibody Test Sales Volume by Type: 2020 VS 2024 VS 2031 (K Units)
Table 22. Global STD Rapid Antibody Test Sales Volume by Type (2020-2025) & (K Units)
Table 23. Global STD Rapid Antibody Test Sales Volume by Type (2026-2031) & (K Units)
Table 24. Global STD Rapid Antibody Test Sales Market Share in Volume by Type (2020-2025)
Table 25. Global STD Rapid Antibody Test Sales Market Share in Volume by Type (2026-2031)
Table 26. Global STD Rapid Antibody Test Price by Type (2020-2025) & (US$/Unit)
Table 27. Global STD Rapid Antibody Test Price by Type (2026-2031) & (US$/Unit)
Table 28. Global STD Rapid Antibody Test Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global STD Rapid Antibody Test Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global STD Rapid Antibody Test Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global STD Rapid Antibody Test Sales Market Share in Value by Application (2020-2025)
Table 32. Global STD Rapid Antibody Test Sales Market Share in Value by Application (2026-2031)
Table 33. Global STD Rapid Antibody Test Sales Volume by Application: 2020 VS 2024 VS 2031 (K Units)
Table 34. Global STD Rapid Antibody Test Sales Volume by Application (2020-2025) & (K Units)
Table 35. Global STD Rapid Antibody Test Sales Volume by Application (2026-2031) & (K Units)
Table 36. Global STD Rapid Antibody Test Sales Market Share in Volume by Application (2020-2025)
Table 37. Global STD Rapid Antibody Test Sales Market Share in Volume by Application (2026-2031)
Table 38. Global STD Rapid Antibody Test Price by Application (2020-2025) & (US$/Unit)
Table 39. Global STD Rapid Antibody Test Price by Application (2026-2031) & (US$/Unit)
Table 40. Global STD Rapid Antibody Test Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global STD Rapid Antibody Test Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global STD Rapid Antibody Test Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global STD Rapid Antibody Test Sales Value by Region (2020-2025) & (%)
Table 44. Global STD Rapid Antibody Test Sales Value by Region (2026-2031) & (%)
Table 45. Global STD Rapid Antibody Test Sales Volume by Region (K Units): 2020 VS 2024 VS 2031
Table 46. Global STD Rapid Antibody Test Sales Volume by Region (2020-2025) & (K Units)
Table 47. Global STD Rapid Antibody Test Sales Volume by Region (2026-2031) & (K Units)
Table 48. Global STD Rapid Antibody Test Sales Volume by Region (2020-2025) & (%)
Table 49. Global STD Rapid Antibody Test Sales Volume by Region (2026-2031) & (%)
Table 50. Global STD Rapid Antibody Test Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global STD Rapid Antibody Test Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions STD Rapid Antibody Test Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions STD Rapid Antibody Test Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions STD Rapid Antibody Test Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions STD Rapid Antibody Test Sales Volume, (2020-2025) & (K Units)
Table 56. Key Countries/Regions STD Rapid Antibody Test Sales Volume, (2026-2031) & (K Units)
Table 57. Blue Cross Bio-Medical (Beijing) Company Information
Table 58. Blue Cross Bio-Medical (Beijing) Introduction and Business Overview
Table 59. Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Blue Cross Bio-Medical (Beijing) STD Rapid Antibody Test Product Offerings
Table 61. Blue Cross Bio-Medical (Beijing) Recent Development
Table 62. Guangzhou Wondfo Biotech Company Information
Table 63. Guangzhou Wondfo Biotech Introduction and Business Overview
Table 64. Guangzhou Wondfo Biotech STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. Guangzhou Wondfo Biotech STD Rapid Antibody Test Product Offerings
Table 66. Guangzhou Wondfo Biotech Recent Development
Table 67. OraSure Company Information
Table 68. OraSure Introduction and Business Overview
Table 69. OraSure STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. OraSure STD Rapid Antibody Test Product Offerings
Table 71. OraSure Recent Development
Table 72. Roche Diagnostics Company Information
Table 73. Roche Diagnostics Introduction and Business Overview
Table 74. Roche Diagnostics STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Roche Diagnostics STD Rapid Antibody Test Product Offerings
Table 76. Roche Diagnostics Recent Development
Table 77. Abbott Company Information
Table 78. Abbott Introduction and Business Overview
Table 79. Abbott STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Abbott STD Rapid Antibody Test Product Offerings
Table 81. Abbott Recent Development
Table 82. Bio-Rad Laboratories Company Information
Table 83. Bio-Rad Laboratories Introduction and Business Overview
Table 84. Bio-Rad Laboratories STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Bio-Rad Laboratories STD Rapid Antibody Test Product Offerings
Table 86. Bio-Rad Laboratories Recent Development
Table 87. BioMerieux Company Information
Table 88. BioMerieux Introduction and Business Overview
Table 89. BioMerieux STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BioMerieux STD Rapid Antibody Test Product Offerings
Table 91. BioMerieux Recent Development
Table 92. Creative Diagnostics Company Information
Table 93. Creative Diagnostics Introduction and Business Overview
Table 94. Creative Diagnostics STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 95. Creative Diagnostics STD Rapid Antibody Test Product Offerings
Table 96. Creative Diagnostics Recent Development
Table 97. Beijing Wantai Biological Pharmacy Company Information
Table 98. Beijing Wantai Biological Pharmacy Introduction and Business Overview
Table 99. Beijing Wantai Biological Pharmacy STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 100. Beijing Wantai Biological Pharmacy STD Rapid Antibody Test Product Offerings
Table 101. Beijing Wantai Biological Pharmacy Recent Development
Table 102. Chembio Diagnostic Systems Company Information
Table 103. Chembio Diagnostic Systems Introduction and Business Overview
Table 104. Chembio Diagnostic Systems STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 105. Chembio Diagnostic Systems STD Rapid Antibody Test Product Offerings
Table 106. Chembio Diagnostic Systems Recent Development
Table 107. InTec Company Information
Table 108. InTec Introduction and Business Overview
Table 109. InTec STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 110. InTec STD Rapid Antibody Test Product Offerings
Table 111. InTec Recent Development
Table 112. Meril Life Company Information
Table 113. Meril Life Introduction and Business Overview
Table 114. Meril Life STD Rapid Antibody Test Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 115. Meril Life STD Rapid Antibody Test Product Offerings
Table 116. Meril Life Recent Development
Table 117. Key Raw Materials Lists
Table 118. Raw Materials Key Suppliers Lists
Table 119. STD Rapid Antibody Test Downstream Customers
Table 120. STD Rapid Antibody Test Distributors List
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. STD Rapid Antibody Test Product Picture
Figure 2. Global STD Rapid Antibody Test Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global STD Rapid Antibody Test Sales Value (2020-2031) & (US$ Million)
Figure 4. Global STD Rapid Antibody Test Sales Volume (2020-2031) & (K Units)
Figure 5. Global STD Rapid Antibody Test Sales Price (2020-2031) & (US$/Unit)
Figure 6. STD Rapid Antibody Test Report Years Considered
Figure 7. Global STD Rapid Antibody Test Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global STD Rapid Antibody Test Players Sales Volume Ranking (2024) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by STD Rapid Antibody Test Revenue in 2024
Figure 10. STD Rapid Antibody Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. Chlamydia Testing Picture
Figure 12. Gonorrhoea Testing Picture
Figure 13. Hepatitis C Testing Picture
Figure 14. HIV Testing Picture
Figure 15. Syphilis Testing Picture
Figure 16. Others Picture
Figure 17. Global STD Rapid Antibody Test Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 18. Global STD Rapid Antibody Test Sales Value Market Share by Type, 2024 & 2031
Figure 19. Global STD Rapid Antibody Test Sales Volume by Type (2020 VS 2024 VS 2031) & (K Units)
Figure 20. Global STD Rapid Antibody Test Sales Volume Market Share by Type, 2024 & 2031
Figure 21. Global STD Rapid Antibody Test Price by Type (2020-2031) & (US$/Unit)
Figure 22. Product Picture of Hospital
Figure 23. Product Picture of Homecare
Figure 24. Product Picture of Diagnostic Centres
Figure 25. Global STD Rapid Antibody Test Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 26. Global STD Rapid Antibody Test Sales Value Market Share by Application, 2024 & 2031
Figure 27. Global STD Rapid Antibody Test Sales Volume by Application (2020 VS 2024 VS 2031) & (K Units)
Figure 28. Global STD Rapid Antibody Test Sales Volume Market Share by Application, 2024 & 2031
Figure 29. Global STD Rapid Antibody Test Price by Application (2020-2031) & (US$/Unit)
Figure 30. North America STD Rapid Antibody Test Sales Value (2020-2031) & (US$ Million)
Figure 31. North America STD Rapid Antibody Test Sales Value by Country (%), 2024 VS 2031
Figure 32. Europe STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 33. Europe STD Rapid Antibody Test Sales Value by Country (%), 2024 VS 2031
Figure 34. Asia Pacific STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 35. Asia Pacific STD Rapid Antibody Test Sales Value by Region (%), 2024 VS 2031
Figure 36. South America STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 37. South America STD Rapid Antibody Test Sales Value by Country (%), 2024 VS 2031
Figure 38. Middle East & Africa STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 39. Middle East & Africa STD Rapid Antibody Test Sales Value by Country (%), 2024 VS 2031
Figure 40. Key Countries/Regions STD Rapid Antibody Test Sales Value (%), (2020-2031)
Figure 41. Key Countries/Regions STD Rapid Antibody Test Sales Volume (%), (2020-2031)
Figure 42. United States STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 43. United States STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
Figure 44. United States STD Rapid Antibody Test Sales Value by Application (%), 2024 VS 2031
Figure 45. Europe STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 46. Europe STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
Figure 47. Europe STD Rapid Antibody Test Sales Value by Application (%), 2024 VS 2031
Figure 48. China STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 49. China STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
Figure 50. China STD Rapid Antibody Test Sales Value by Application (%), 2024 VS 2031
Figure 51. Japan STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 52. Japan STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
Figure 53. Japan STD Rapid Antibody Test Sales Value by Application (%), 2024 VS 2031
Figure 54. South Korea STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 55. South Korea STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
Figure 56. South Korea STD Rapid Antibody Test Sales Value by Application (%), 2024 VS 2031
Figure 57. Southeast Asia STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 58. Southeast Asia STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
Figure 59. Southeast Asia STD Rapid Antibody Test Sales Value by Application (%), 2024 VS 2031
Figure 60. India STD Rapid Antibody Test Sales Value, (2020-2031) & (US$ Million)
Figure 61. India STD Rapid Antibody Test Sales Value by Type (%), 2024 VS 2031
Figure 62. India STD Rapid Antibody Test Sales Value by Application (%), 2024 VS 2031
Figure 63. STD Rapid Antibody Test Industrial Chain
Figure 64. STD Rapid Antibody Test Manufacturing Cost Structure
Figure 65. Channels of Distribution (Direct Sales, and Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of STD Rapid Antibody Test in 2025?
The global market size of STD Rapid Antibody Test in 2025 was 74.4 Million USD.
What was the global market size of STD Rapid Antibody Test in 2031?
What is the annual compound growth rate of the global STD Rapid Antibody Test market size from 2025 to 2031?
Which companies rank high in the global STD Rapid Antibody Test market?
Which region is expected to have the highest market share?
Related Reports
STD Rapid Antibody Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for STD Rapid Antibody Test was estimated to be worth US$ 74.39 million in 2025 and is projected to reach US$ 105 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 140
USD 3950.00
(Single User License)
Global STD Rapid Antibody Test Market Research Report 2026
The global STD Rapid Antibody Test market was valued at US$ 74.39 million in 2025 and is anticipated to reach US$ 105 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 126
USD 2900.00
(Single User License)
Global STD Rapid Antibody Test Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global STD Rapid Antibody Test market size was US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 94
USD 4250.00
(Single User License)
Global STD Rapid Antibody Test Market Outlook, In‑Depth Analysis & Forecast to 2031
The global STD Rapid Antibody Test market is projected to grow from US$ 71.1 million in 2024 to US$ 100 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 163
USD 4900.00
(Single User License)
Global STD Rapid Antibody Test Market Research Report 2025
The global market for STD Rapid Antibody Test was valued at US$ 71.1 million in the year 2024 and is projected to reach a revised size of US$ 100 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-01-13
Pages: 90
USD 2900.00
(Single User License)
Global STD Rapid Antibody Test Market Research Report 2024
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
Published Date: 2024-01-17
Pages: 93
USD 2900.00
(Single User License)
STD Rapid Antibody Test- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for STD Rapid Antibody Test was estimated to be worth US$ 74.39 million in 2025 and is projected to reach US$ 105 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-06-16
Pages: 140
USD 3950.00 (Single User License)Global STD Rapid Antibody Test Market Research Report 2026
The global STD Rapid Antibody Test market was valued at US$ 74.39 million in 2025 and is anticipated to reach US$ 105 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-04-17
Pages: 126
USD 2900.00 (Single User License)Global STD Rapid Antibody Test Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global STD Rapid Antibody Test market size was US$ 71.1 million in 2024 and is forecast to a readjusted size of US$ 100 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 94
USD 4250.00 (Single User License)Global STD Rapid Antibody Test Market Outlook, In‑Depth Analysis & Forecast to 2031
The global STD Rapid Antibody Test market is projected to grow from US$ 71.1 million in 2024 to US$ 100 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 163
USD 4900.00 (Single User License)Global STD Rapid Antibody Test Market Research Report 2025
The global market for STD Rapid Antibody Test was valued at US$ 71.1 million in the year 2024 and is projected to reach a revised size of US$ 100 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-01-13
Pages: 90
USD 2900.00 (Single User License)Global STD Rapid Antibody Test Market Research Report 2024
Sexually transmitted diseases (STDs) are those spread from a person to person through sexual contact. After the incubation period has passed, most STDs can be diagnosed via antibody-specific blood tests. Some STDs are also accompanied by lesions and can be diagnosed via swab, culture, or urine tests as well.
Published: 2024-01-17
Pages: 93
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now